Avanos Medical, Inc. (AVNS)
| Market Cap | 1.58B |
| Revenue (ttm) | 737.80M |
| Net Income (ttm) | 2.40M |
| Shares Out | 48.07M |
| EPS (ttm) | 0.04 |
| PE Ratio | 822.00 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 148,668 |
| Open | 32.29 |
| Previous Close | 32.92 |
| Day's Range | 32.41 - 32.94 |
| 52-Week Range | 30.96 - 53.61 |
| Beta | 0.91 |
| Analysts | Buy |
| Price Target | 43.00 (+30.8%) |
| Est. Earnings Date | Nov 2, 2021 |
About AVNS
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management...
Financial Performance
In 2020, Avanos Medical's revenue was $714.80 million, an increase of 2.47% compared to the previous year's $697.60 million. Losses were -$27.20 million, -40.74% less than in 2019.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for Avanos Medical stock is "Buy." The 12-month stock price forecast is 43.00, which is an increase of 30.78% from the latest price.
News
Why Is Avanos Medical (AVNS) Down 2.2% Since Last Earnings Report?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Avanos Medical (AVNS) Q2 Earnings Lag Estimates, Revenues Top
Avanos Medical's (AVNS) second-quarter 2021 results gains from strength in Pain Management segment.
Avanos Medical Shares Fall As Higher Transportation Costs Hit Q2 Margins; Lowers FY21 Guidance
Avanos Medical Inc (NYSE: AVNS) reported a second-quarter FY21 adjusted EPS of $0.21, missing the consensus of $0.23. The sales of $186.4 million increased 14% Y/Y, beating the analyst estimate of $180....
Avanos Medical (AVNS) Q2 Earnings Miss Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of -8.70% and 2.36%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical: Q2 Earnings Insights
Shares of Avanos Medical (NYSE:AVNS) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 61.54% year over year to $0.21, which missed the estimate of $0.23.
Avanos Medical, Inc. Announces Second Quarter 2021 Results
ALPHARETTA, Ga., Aug. 3, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2021 financial results.
Avanos Medical (AVNS) Earnings Expected to Grow: Should You Buy?
Avanos Medical (AVNS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Avanos Medical (AVNS) Beat Estimates Again in Its Next Earnings Report?
Avanos Medical (AVNS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Avanos Medical, Inc. To Webcast Conference Call Discussing Second Quarter 2021 Financial Results
ALPHARETTA, Ga., July 27, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2021 on Tues...
Here's Why You Should Retain Avanos (AVNS) Stock for Now
Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.
Avanos Medical, Inc. Appoints Moji James as Senior Vice President & General Counsel
ALPHARETTA, Ga., July 12, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Moji James has been appointed senior vice president & general counsel.
Avanos Medical, Inc. to Present at the 2021 Raymond James Human Health Innovation Conference
ALPHARETTA, Ga., June 18, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present and participate in an analyst-led fireside chat at ...
Here's Why You Should Hold on to Avanos (AVNS) Stock for Now
Investors continue to be optimistic about Avanos (AVNS), owing to its strong product line and focus on its R&D.
Charles River Laboratories International Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
NEW YORK, May 10, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600: S&P MidCap 400 constituent Charles River Laboratories I...
Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates
Avanos Medical (AVNS) continues to gain from its core Chronic Care segment in the first quarter.
Avanos Medical (AVNS) Beats Q1 Earnings and Revenue Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of 27.78% and 2.30%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical, Inc. Announces First Quarter 2021 Results
ALPHARETTA, Ga., May 7, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2021 financial results.
Avanos Medical, Inc. To Webcast Conference Call Discussing First Quarter 2021 Financial Results
ALPHARETTA, Ga., April 30, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2021 on Frid...
Avanos Medical (AVNS) Earnings Expected to Grow: Should You Buy?
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avanos Medical (AVNS) Down 1% Since Last Earnings Report: Can It Rebound?
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Avanos Medical, Inc. to Present at the KeyBanc Life Sciences & MedTech Investor Forum
ALPHARETTA, Ga., March 16, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the Virtual KeyBanc Life Sciences & MedTech Inv...
Here's Why You Should Retain Avanos Medical (AVNS) Stock Now
Investor confidence is high in Avanos Medical (AVNS) stock, courtesy of its solid prospects.
Avanos Medical, Inc. to Present at the Virtual Raymond James 42nd Annual Institutional Investors Conference
ALPHARETTA, Ga., Feb. 24, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present at the Virtual Raym...
Avanos Medical (AVNS) Q4 Earnings and Revenues Top Estimates
Avanos Medical (AVNS) continues to gain from its core Chronic Care segment in the fourth quarter.
Avanos Medical (AVNS) Tops Q4 Earnings and Revenue Estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of 27.27% and 0.67%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?